CanSino Biologics Inc. (688185.SS)

CNY 63.42

(0.21%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 9.36 Billion 11.46 Billion 11.87 Billion 6.74 Billion 1.78 Billion 795.87 Million
Total Current Assets 5.18 Billion 7.73 Billion 9.28 Billion 5.42 Billion 794.24 Million 221 Million
Cash And Short Term Investments 4.12 Billion 5.94 Billion 7.78 Billion 5.11 Billion 754.79 Million 197.38 Million
Cash and Cash Equivalents 2.05 Billion 3.39 Billion 5.45 Billion 4.44 Billion 202.45 Million 57.38 Million
Short Term Investments 2.07 Billion 2.55 Billion 2.32 Billion 666.64 Million 552.34 Million 140 Million
Net Receivables 647.13 Million 963.51 Million 252.76 Million 22.39 Million 17.89 Million -135.54 Million
Inventory 387.45 Million 677.77 Million 875.62 Million 170.51 Million 16.33 Million 8.49 Million
Other Current Assets 16.37 Million 142.1 Million 378.8 Million 114.06 Million 5.21 Million 150.67 Million
Total Non-Current Assets 4.18 Billion 3.73 Billion 2.58 Billion 1.32 Billion 990.25 Million 574.87 Million
Net PPE 3.19 Billion 3.08 Billion 2.21 Billion 881.91 Million 589.69 Million 507.44 Million
Good Will And Intangible Assets 205.64 Million 258.73 Million 198.3 Million 72.29 Million 57.21 Million 51.25 Million
Good Will - - - - - -
Intangible Assets 205.64 Million 258.73 Million 198.3 Million 72.29 Million 57.21 Million 51.25 Million
Long-Term Investments 446.55 Million -2.5 Billion -2.28 Billion -401.19 Million -245.47 Million -
Tax Assets 258.69 Million 196.41 Million - - 243.49 Million -
Other Non Current Assets 84.56 Million 2.7 Billion 2.44 Billion 774.41 Million 345.32 Million 16.16 Million
Other Assets - - - - - -
Total Liabilities 3.86 Billion 4.22 Billion 3.32 Billion 677.21 Million 313.98 Million 293.55 Million
Total Current Liabilities 2.56 Billion 2.94 Billion 2.87 Billion 412.85 Million 124.29 Million 106.68 Million
Account Payables 103.97 Million 253.12 Million 842.56 Million 60.57 Million 6.17 Million 6.65 Million
Tax Payables - 23.71 Million 34.53 Million 1.15 Million 490 Thousand 233 Thousand
Short Term Debt 1.46 Billion 1.62 Billion 1.11 Billion 48.74 Million 29.04 Million 239.49 Thousand
Deferred Revenue 3.56 Million 1.48 Million 193.21 Million 420 Thousand 577.57 Thousand 233 Thousand
Other Current Liabilities 992.24 Million 1.06 Billion 727.18 Million 303.11 Million 88.5 Million 99.56 Million
Total Non Current Liabilities 1.3 Billion 1.28 Billion 451.36 Million 264.36 Million 189.68 Million 186.87 Million
Long-Term Debt 1.07 Billion 1.07 Billion 262.84 Million 93.79 Million 137.75 Million 150 Million
Deferred Revenue Non Current 190.17 Million 204.99 Million 187.95 Million 170.57 Million 51.92 Million 36.87 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -14.99 Million -878 Million - -90 Million -130 Million 36.87 Million
Other Liabilities - - - - - -
Total Equity 5.28 Billion 7.24 Billion 8.54 Billion 6.07 Billion 1.47 Billion 502.31 Million
Stock Holders Equity 5.27 Billion 6.74 Billion 7.99 Billion 6.07 Billion 1.47 Billion 502.31 Million
Common Stock 247.44 Million 247.45 Million 247.45 Million 247.45 Million 222.65 Million 160.95 Million
Retained Earnings -1.55 Billion -75.68 Million 1.03 Billion -764.69 Million -368.05 Million -211.28 Million
Accumulated other comprehensive income 17.09 Million 170.62 Million 160.41 Million 45.23 Million 1.61 Billion 552.65 Million
Common Stock Equity 5.27 Billion 6.74 Billion 7.99 Billion 6.07 Billion 1.47 Billion 502.31 Million
Capital Lease Obligation 175.18 Million 247.04 Million 254.02 Million 12.37 Million 16.56 Million -
Total Investments 2.51 Billion 50.11 Million 45.31 Million 265.44 Million 306.86 Million 140 Million
Total Debt 2.71 Billion 2.7 Billion 1.37 Billion 142.53 Million 166.79 Million 150 Million
Net Debt 656.66 Million -694.19 Million -4.08 Billion -4.3 Billion -35.65 Million 92.61 Million

Balance Sheet Charts